ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 28 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133 | -17.4% | 60,913 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $161 | +114.7% | 60,913 | -0.3% | 0.00% | – |
| Q1 2023 | $75 | -25.0% | 61,081 | +0.0% | 0.00% | – |
| Q4 2022 | $100 | -99.9% | 61,059 | -0.7% | 0.00% | – |
| Q3 2022 | $77,000 | +28.3% | 61,479 | +0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -45.0% | 61,467 | -10.9% | 0.00% | – |
| Q1 2022 | $109,000 | +29.8% | 68,953 | +13.7% | 0.00% | – |
| Q4 2021 | $84,000 | -34.9% | 60,629 | -1.7% | 0.00% | – |
| Q3 2021 | $129,000 | -25.0% | 61,654 | -0.5% | 0.00% | – |
| Q2 2021 | $172,000 | -27.1% | 61,940 | -0.1% | 0.00% | -100.0% |
| Q1 2021 | $236,000 | +59.5% | 61,992 | 0.0% | 0.00% | – |
| Q4 2020 | $148,000 | +43.7% | 61,992 | +2.1% | 0.00% | – |
| Q3 2020 | $103,000 | -10.4% | 60,688 | -0.6% | 0.00% | -100.0% |
| Q2 2020 | $115,000 | +379.2% | 61,083 | +251.1% | 0.00% | – |
| Q1 2020 | $24,000 | -70.7% | 17,400 | +1.2% | 0.00% | – |
| Q4 2019 | $82,000 | – | 17,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 277,852 | $885,000 | 0.08% |
| CHIRON CAPITAL MANAGEMENT, LLC | 10,000 | $38,000 | 0.03% |
| BRAVE ASSET MANAGEMENT INC | 10,000 | $38,000 | 0.01% |
| Disciplined Investments, LLC | 5,189 | $20,000 | 0.01% |
| Cedar Mountain Advisors, LLC | 5,651 | $22,000 | 0.01% |
| Crescent Grove Advisors, LLC | 10,000 | $38,000 | 0.00% |
| SITTNER & NELSON, LLC | 1,000 | $4,000 | 0.00% |
| Banque Cantonale Vaudoise | 11,268 | $42,000 | 0.00% |
| Zions Bancorporation, N.A. | 5,000 | $19,000 | 0.00% |
| CIBC WORLD MARKET INC. | 61,992 | $236,000 | 0.00% |